Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001241322-04-000001
Filing Date
2004-02-18
Accepted
2004-02-18 16:41:36
Documents
1
Period of Report
2004-02-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3973
  Complete submission text file 0001241322-04-000001.txt   5884
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Issuer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address C/O GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM MA 01702 5086209700
MEADE HARRY (Reporting) CIK: 0001241322 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21794 | Film No.: 04613639